Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07337174

Study to Compare and Evaluate the Safety and Pharmacokinetics After Subcutaneous Injection of HUC2-676 or HUC2-676-R in Healthy Adult Subjects

A Randomized, Open-label, Single Dose, Two-way, Crossover, Phase 1 Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics After Subcutaneous Injection of HUC2-676 or HUC2-676-R in Healthy Adult Subjects

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Huons Co., Ltd. · Industry
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Accepted

Summary

The trial uses a randomized, open-label, single-dose administration per period, and a 2 x 2 crossover design where subjects receive both treatments sequentially with a washout.

Conditions

Interventions

TypeNameDescription
DRUGHUC2-676subcutaneous injection
DRUGHUC2-676-Rsubcutaneous injection

Timeline

Start date
2026-01-25
Primary completion
2026-03-24
Completion
2026-03-24
First posted
2026-01-13
Last updated
2026-01-13

Source: ClinicalTrials.gov record NCT07337174. Inclusion in this directory is not an endorsement.